Table 2 Patient characteristics in those with GAVE at GAVE diagnosis (n=216)
Characteristic | GAVE n (%) or median (IQR 25th-75th) | p-value |
|---|---|---|
Demographics | ||
Age at GAVE diagnosis, years | 55.94 (47.25-66.46) | |
SSc durationa at GAVE diagnosis, years | 4.00 (0.84-12.42) | |
Limited disease subtype | 5.25 (0.50-16.08) | |
Diffuse disease subtype | 3.08 (1.25-9.59) | 0.003 |
Female | 188 (87.0%) | |
Diffuse disease subtype | 72 (35.3%) | |
Caucasian | 183 (91.5%) | |
Follow-up from GAVE diagnosis, years | 6.88 (2.99-11.16) | |
Serological markers at GAVE diagnosis | ||
inflammatory markers | ||
CRP | 4.00 (2.75-7.50) | |
ESR | 17.50 (9.00-27.00) | |
platelets | 298.00 (256.00-351.00) | |
albumin | 37.00 (35.00-40.00) | |
Anaemia at GAVE diagnosis | 19 (31.7%) | |
Drop in Hb of 10g pre-GAVE diagnosis | 91 (53.8%) | |
Drop in Hb of 10g post GAVE diagnosis | 75 (37.5%) | |
Increase in MRSS in preceding 12months of dx | 15 (24.2%) | |
Clinical markers at GAVE diagnosis | ||
Increasing breathlessness | 46 (23.5%) | |
Decrease in DLCO | 71 (42.3%) | |